Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 13, 2012
Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting
Cecelia A Bellcross, Sara R Bedrosian, Elvan Daniels, et al.
JAMA Oncology
|
May 31, 2026
Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study
Yiwey Shieh, Rachel S Heise, Lisa Madlensky, et al.
JAMA Internal Medicine
|
December 12, 2025
Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial
Kirkpatrick B Fergus, Katherine S Ross, Maren T Scheuner, et al.
JAMA
|
December 12, 2025
Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial
Laura J Esserman, Allison S Fiscalini, Arash Naeim, et al.
Research Square
|
November 19, 2025
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design
Allison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
NPJ Breast Cancer
|
May 23, 2026
WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design
Allison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
British Journal of Cancer
|
June 20, 2019
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
Frank Qian, Matti A Rookus, Goska Leslie, et al.
Nature Communications
|
February 18, 2021
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Juliette Coignard, Michael Lush, Jonathan Beesley, et al.
Nature Communications
|
May 15, 2021
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Juliette Coignard, Michael Lush, Jonathan Beesley, et al.
NPJ Breast Cancer
|
November 9, 2019
The <i>FANCM</i>:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Gisella Figlioli, Massimo Bogliolo, Irene Catucci, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 13, 2012
Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting
Cecelia A Bellcross, Sara R Bedrosian, Elvan Daniels, et al.
JAMA Oncology
|
May 31, 2026
Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study
Yiwey Shieh, Rachel S Heise, Lisa Madlensky, et al.
JAMA Internal Medicine
|
December 12, 2025
Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial
Kirkpatrick B Fergus, Katherine S Ross, Maren T Scheuner, et al.
JAMA
|
December 12, 2025
Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial
Laura J Esserman, Allison S Fiscalini, Arash Naeim, et al.
Research Square
|
November 19, 2025
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design
Allison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
NPJ Breast Cancer
|
May 23, 2026
WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design
Allison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
British Journal of Cancer
|
June 20, 2019
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
Frank Qian, Matti A Rookus, Goska Leslie, et al.
Nature Communications
|
February 18, 2021
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Juliette Coignard, Michael Lush, Jonathan Beesley, et al.
Nature Communications
|
May 15, 2021
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Juliette Coignard, Michael Lush, Jonathan Beesley, et al.
NPJ Breast Cancer
|
November 9, 2019
The <i>FANCM</i>:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Gisella Figlioli, Massimo Bogliolo, Irene Catucci, et al.
Page
of 8